Takeda made R&D deals in neurological disorders and with academic institutes, China's crackdown on pollution has caused some supply issues for the pharma industry, Merck KGaA plans further manufacturing expansions in Asia, and more.Original Article
FiercePharmaAsia—More Takeda deals, China’s pharma supply issues, Merck KGaA expansion
